Symptoms
  Diagnosis
  Treatment
  Research
  Articles
  Clinical Trials
  Current Grants
  Research Symposia
  Prevalence
  Case Definition
  Profiles

CFS Assessment Symposium
Neuroendocrine Aspects of Chronic Fatigue Syndrome

Literature Review

  1. Allain TJ, Bearn JA, Coskeran P, et al: Changes in growth hormone, insulin, insulinlike growth factors (IGFs), and IGF-binding protein-1 in chronic fatigue syndrome. Biol Psychiatry 1997; 41: 567-73.
  2. Bakheit AM, Behan PO, Dinan TG, Gray CE, O'Keane V: Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. BMJ 1992; 304: 1010-2.
  3. Bearn J, Allain T, Coskeran P, et al: Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome. Biol Psychiatry 1995; 37: 245-52.
  4. Bennett AL, Mayes DM, Fagioli LR, Guerriero R, Komaroff AL. Somatomedin C (insulin-like growth factor I) levels in patients with chronic fatigue syndrome. J Psychiatr Res. 1997 Jan-1997 Feb 28; 31(1):91-6.
  5. Berwaerts J, Moorkens G, Abs R: Secretion of growth hormone in patients with chronic fatigue syndrome. Growth Horm IGF Res 1998; 8 Suppl B: 127-9.
  6. Buchwald D, Umali J, Stene M: Insulin-like growth factor-I (somatomedin C) levels in chronic fatigue syndrome and fibromyalgia. J Rheumatol 1996; 23: 739-42.
  7. Cannon JG, Angel JB, Abad LW, et al: Hormonal influences on stress-induced neutrophil mobilization in health and chronic fatigue syndrome. J Clin Immunol 1998; 18: 291-8.
  8. Cleare AJ, Sookdeo SS, Jones J, O'Keane V, Miell JP: Integrity of the growth hormone/insulin-like growth factor system is maintained in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 2000; 85: 1433-9.
  9. Cleare AJ, Heap E, Malhi GS, Wessely S, O'Keane V, Miell J: Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet 1999; 353: 455-8.
  10. Cleare AJ, Bearn J, Allain T, et al: Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affect Disord 1995; 34: 283-9.
  11. Crofford LJ: The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and chronic fatigue syndrome. Z Rheumatol 1998; 57 Suppl 2: 67-71.
  12. De Becker P, De Meirleir K, Joos E, et al: Dehydroepiandrosterone (DHEA) response to i.v. ACTH in patients with chronic fatigue syndrome. Horm Metab Res 1999; 31: 18-21.
  13. Demitrack MA. Neuroendocrine aspects of chronic fatigue syndrome: a commentary. Am J Med. 1998 Sep 28; 105(3A):11S-14S.
  14. Demitrack MA: Neuroendocrine correlates of chronic fatigue syndrome: a brief review. J Psychiatr Res 1997; 31: 69-82.
  15. Demitrack MA, Dale JK, Straus SE, et al: Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73: 1224-34.
  16. Dinan TG, Majeed T, Lavelle E, Scott LV, Berti C, Behan P: Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychoneuroendocrinology 1997; 22: 261-7.
  17. Glaser R, Kiecolt-Glaser JK: Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome. Am J Med 1998; 105: 35S-42S.
  18. Harlow BL, Signorello LB, Hall JE, Dailey C, Komaroff AL: Reproductive correlates of chronic fatigue syndrome. Am J Med 1998; 105: 94S-99S.
  19. Hudson M, Cleare AJ: The 1microg short Synacthen test in chronic fatigue syndrome. Clin Endocrinol (Oxf) 1999; 51: 625-30.
  20. Kavelaars A, Kuis W, Knook L, Sinnema G, Heijnen CJ: Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. J Clin Endocrinol Metab 2000; 85: 692-6.
  21. Knook L, Kavelaars A, Sinnema G, Kuis W, Heijnen CJ: High nocturnal melatonin in adolescents with chronic fatigue syndrome. J Clin Endocrinol Metab 2000; 85: 3690-2.
  22. Korszun A, Young EA, Engleberg NC, et al: Follicular phase hypothalamic-pituitary-gonadal axis function in women with fibromyalgia and chronic fatigue syndrome. J Rheumatol 2000; 27: 1526-30.
  23. Korszun A, Sackett-Lundeen L, Papadopoulos E, et al: Melatonin levels in women with fibromyalgia and chronic fatigue syndrome. J Rheumatol 1999; 26: 2675-80.
  24. Krupp LB, Pollina D: Neuroimmune and neuropsychiatric aspects of chronic fatigue syndrome. Adv Neuroimmunol 1996; 6: 155-67.
  25. Kuratsune H, Yamaguti K, Sawada M, et al: Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome. Int J Mol Med 1998; 1: 143-6.
  26. Leese G, Chattington P, Fraser W, Vora J, Edwards R, Williams G: Short-term night-shift working mimics the pituitary-adrenocortical dysfunction in chronic fatigue syndrome. J Clin Endocrinol Metab 1996; 81: 1867-70.
  27. MacHale SM, Cavanagh JT, Bennie J, Carroll S, Goodwin GM, Lawrie SM: Diurnal variation of adrenocortical activity in chronic fatigue syndrome. Neuropsychobiology 1998; 38: 213-7.
  28. McKenzie R, O'Fallon A, Dale J, et al: Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA 1998; 280: 1061-6.
  29. Moldofsky H: Sleep, neuroimmune and neuroendocrine functions in fibromyalgia and chronic fatigue syndrome. Adv Neuroimmunol 1995; 5: 39-56.
  30. Moorkens G, Berwaerts J, Wynants H, Abs R: Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome. Clin Endocrinol (Oxf) 2000; 53: 99-106.
  31. Moorkens G, Wynants H, Abs R: Effect of growth hormone treatment in patients with chronic fatigue syndrome: a preliminary study. Growth Horm IGF Res 1998; 8 Suppl B: 131-3.
  32. Neeck G, Crofford LJ: Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome. Rheum Dis Clin North Am 2000; 26: 989-1002.
  33. Scott LV, Svec F, Dinan T: A preliminary study of dehydroepiandrosterone response to low-dose ACTH in chronic fatigue syndrome and in healthy subjects. Psychiatry Res 2000; 97: 21-28.
  34. Scott LV, Teh J, Reznek R, Martin A, Sohaib A, Dinan TG: Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study. Psychoneuroendocrinology 1999; 24: 759-68.
  35. Scott LV, Medbak S, Dinan TG: Desmopressin augments pituitary-adrenal responsivity to corticotropin- releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers. Biol Psychiatry 1999; 45: 1447-54.
  36. Scott LV, Dinan TG: The neuroendocrinology of chronic fatigue syndrome: focus on the hypothalamic-pituitary-adrenal axis. Funct Neurol 1999; 14: 3-11.
  37. Scott LV, Salahuddin F, Cooney J, Svec F, Dinan TG: Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health. J Affect Disord 1999; 54: 129-37.
  38. Scott LV, Burnett F, Medbak S, Dinan TG: Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychol Med 1998; 28: 285-93.
  39. Scott LV, Dinan TG: Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers. J Affect Disord 1998; 47: 49-54.
  40. Scott LV, Medbak S, Dinan TG: Blunted adrenocorticotropin and cortisol responses to corticotropin- releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr Scand 1998; 97: 450-7.
  41. Scott LV, Medbak S, Dinan TG: The low dose ACTH test in chronic fatigue syndrome and in health. Clin Endocrinol (Oxf) 1998; 48: 733-7.
  42. Sharma A, Oyebode F, Kendall MJ, Jones DA: Recovery from chronic fatigue syndrome associated with changes in neuroendocrine function. J R Soc Med 2001; 94: 26-7.
  43. Sharpe M, Clements A, Hawton K, Young AH, Sargent P, Cowen PJ: Increased prolactin response to buspirone in chronic fatigue syndrome. J Affect Disord 1996; 41: 71-6.
  44. Sharpe M, Hawton K, Clements A, Cowen PJ. Increased brain serotonin function in men with chronic fatigue syndrome. BMJ. 1997 Jul 19; 315(7101):164-5.
  45. Streeten DH, Anderson GH Jr: The role of delayed orthostatic hypotension in the pathogenesis of chronic fatigue. Clin Auton Res 1998; 8: 119-24.
  46. Streeten DH: The nature of chronic fatigue. JAMA 1998; 280: 1094-5.
  47. Strickland P, Morriss R, Wearden A, Deakin B: A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls. J Affect Disord 1998; 47: 191-4.
  48. van de Luit L, van der Meulen J, Cleophas TJ, Zwinderman AH: Amplified amplitudes of circadian rhythms and nighttime hypotension in patients with chronic fatigue syndrome: improvement by inopamil but not by melatonin. Angiology 1998; 49: 903-8.
  49. Williams G, Pirmohamed J, Minors D, et al: Dissociation of body-temperature and melatonin secretion circadian rhythms in patients with chronic fatigue syndrome. Clin Physiol 1996; 16: 327-37.
  50. Wood B, Wessely S, Papadopoulos A, Poon L, Checkley S: Salivary cortisol profiles in chronic fatigue syndrome. Neuropsychobiology 1998; 37: 1-4.
  51. Yatham LN, Morehouse RL, Chisholm BT, Haase DA, MacDonald DD, Marrie TJ: Neuroendocrine assessment of serotonin (5-HT) function in chronic fatigue syndrome. Can J Psychiatry 1995; 40: 93-6.
  52. Young AH, Sharpe M, Clements A, Dowling B, Hawton KE, Cowen PJ: Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia). Biol Psychiatry 1998; 43: 236-7.